ACADIA Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly) Trends

ACADIA Pharmaceuticals, Inc. (ACAD)

24.56 -0.08 (-0.32%) USD | NASDAQ | Feb 27, 16:00

23.90 -0.66 (-2.69%) Pre-Market: 08:31

View EPS Diluted from Other Gain/Loss (Quarterly) for ACAD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Madrigal Pharmaceuticals, Inc.	--
Marker Therapeutics, Inc.	--
Agilent Technologies, Inc.	--
BioMarin Pharmaceutical, Inc.	--